143 related articles for article (PubMed ID: 22614681)
1. Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer: do they have prognostic impact?
Vallböhmer D; Bollschweiler E; Brabender J; Wedemeyer I; Grimminger PP; Metzger R; Schröder W; Gutschow C; Hölscher AH; Drebber U
Int J Colorectal Dis; 2012 Oct; 27(10):1295-301. PubMed ID: 22614681
[TBL] [Abstract][Full Text] [Related]
2. β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis.
Drebber U; Madeja M; Odenthal M; Wedemeyer I; Mönig SP; Brabender J; Bollschweiler E; Hölscher AH; Schneider PM; Dienes HP; Vallböhmer D
Int J Colorectal Dis; 2011 Sep; 26(9):1127-34. PubMed ID: 21538055
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essential.
Hermanek P; Merkel S; Hohenberger W
Anticancer Res; 2013 Feb; 33(2):559-66. PubMed ID: 23393349
[TBL] [Abstract][Full Text] [Related]
4. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
Puetz K; Bollschweiler E; Semrau R; Mönig SP; Hölscher AH; Drebber U
Histopathology; 2019 Apr; 74(5):731-743. PubMed ID: 30636069
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
7. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
9. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
[TBL] [Abstract][Full Text] [Related]
10. Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients.
Jessberger J; Erlenbach-Wünsch K; Posselt R; Haderlein M; Agaimy A; Fietkau R; Hartmann A; Distel L
J Dig Dis; 2017 May; 18(5):283-291. PubMed ID: 28342240
[TBL] [Abstract][Full Text] [Related]
11. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172
[TBL] [Abstract][Full Text] [Related]
13. Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancer.
Elezkurtaj S; Moser L; Budczies J; Müller AJ; Bläker H; Buhr HJ; Dietel M; Kruschewski M
Pathol Res Pract; 2013 Jul; 209(7):424-8. PubMed ID: 23706942
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression.
Eich HT; Stepien A; Zimmermann C; Hellmich M; Metzger R; Hölscher A; Müller RP
Strahlenther Onkol; 2011 Apr; 187(4):225-30. PubMed ID: 21424305
[TBL] [Abstract][Full Text] [Related]
15. Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer.
Jäger T; Neureiter D; Urbas R; Klieser E; Hitzl W; Emmanuel K; Dinnewitzer A
Dis Colon Rectum; 2017 Aug; 60(8):815-826. PubMed ID: 28682967
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
Jao SW; Chen SF; Lin YS; Chang YC; Lee TY; Wu CC; Jin JS; Nieh S
Ann Surg Oncol; 2012 Oct; 19(11):3432-40. PubMed ID: 22739652
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of residual rectal carcinoma following preoperative radiochemotherapy.
Micev M; Micev-Cosić M; Todorović V; Krsmanović M; Krivokapić Z; Popović M; Barisić G; Marković V; Jelić-Radosević L; Popov I
Acta Chir Iugosl; 2004; 51(2):99-108. PubMed ID: 15771300
[TBL] [Abstract][Full Text] [Related]
19. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.
MacGregor TP; Maughan TS; Sharma RA
J Clin Pathol; 2012 Oct; 65(10):867-71. PubMed ID: 22734005
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
